Table of Contents
Chapter 01: The Nursing Process and Patient-Centered Care ............................................................................
... [Show More] 2
Chapter 02: Drug Development and Ethical Considerations ............................................................................... 9
Chapter 03: Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics .................................................. 17
Chapter 04: Pharmacogenetics ......................................................................................................................... 31
Chapter 05: Complementary and Alternative Therapies .................................................................................. 34
Chapter 06: Pediatric Considerations ............................................................................................................... 39
Chapter 07: Geriatric Considerations ................................................................................................................ 46
Chapter 08: Drugs of Abuse .............................................................................................................................. 52
Chapter 09: Safety and Quality ......................................................................................................................... 58
Chapter 10: Drug Administration ...................................................................................................................... 64
Chapter 11: Drug Calculations .......................................................................................................................... 69
Chapter 12: Fluid Volume and Electrolytes ....................................................................................................... 74
Chapter 13: Vitamin and Mineral Replacement ............................................................................................... 83
Chapter 14: Nutritional Support ....................................................................................................................... 90
Chapter 15: Adrenergic Agonists and Antagonists ............................................................................................ 98
Chapter 16: Cholinergic Agonists and Antagonists ......................................................................................... 104
Chapter 17: Stimulants ................................................................................................................................... 110
Chapter 18: Depressants ................................................................................................................................. 114
Chapter 19: Antiseizure Drugs ........................................................................................................................ 120
Chapter 20: Drugs for Parkinson Disease and Alzheimer Disease ................................................................... 127
Chapter 21: Drugs for Neuromuscular Disorders and Muscle Spasms ........................................................... 133
Chapter 22: Antipsychotics and Anxiolytics .................................................................................................... 139
Chapter 23: Antidepressants and Mood Stabilizers ........................................................................................ 146
Chapter 24: Antiinflammatories ..................................................................................................................... 153
Chapter 25: Analgesics .................................................................................................................................... 160
Chapter 26: Antibacterials .............................................................................................................................. 167
Chapter 27: Antituberculars, Antifungals, and Antivirals ................................................................................ 183
Chapter 28: Peptides, Antimalarials, and Anthelmintics ................................................................................ 191
Chapter 29: HIV- and AIDS-Related Drugs....................................................................................................... 194
Chapter 30: Transplant Drugs ......................................................................................................................... 198
Chapter 31: Vaccines ...................................................................................................................................... 201
Chapter 32: Anticancer Drugs ......................................................................................................................... 205
Chapter 33: Targeted Therapies to Treat Cancer ............................................................................................ 209
Chapter 34: Biologic Response Modifiers ....................................................................................................... 212
Chapter 35: Upper Respiratory Disorders ....................................................................................................... 216
Chapter 36: Lower Respiratory Disorders ....................................................................................................... 220
Chapter 37: Cardiac Glycosides, Antianginals, and Antidysrhythmics ........................................................... 226
Chapter 38: Diuretics ...................................................................................................................................... 233
Chapter 39: Antihypertensives ....................................................................................................................... 237
Chapter 40: Anticoagulants, Antiplatelets, and Thrombolytics ...................................................................... 243
Chapter 41: Antihyperlipidemics and Peripheral Vasodilators ....................................................................... 250
Chapter 42: Gastrointestinal Tract Disorders ................................................................................................. 255
Chapter 43: Antiulcer Drugs ............................................................................................................................ 261
Chapter 44: Eye and Ear Disorders ................................................................................................................. 267
Chapter 45: Dermatologic Disorders ............................................................................................................... 271
Chapter 46: Pituitary, Thyroid, Parathyroid, and Adrenal Disorders .............................................................. 276
Chapter 47: Antidiabetics ............................................................................................................................... 283
Chapter 48: Urinary Disorders ........................................................................................................................ 289
Chapter 49: Pregnancy and Preterm Labor ..................................................................................................... 294
Chapter 50: Labor, Delivery, and Postpartum................................................................................................. 300
Chapter 51: Neonatal and Newborn ............................................................................................................... 305
Chapter 52: Women’s Reproductive Health ................................................................................................... 307
Chapter 53: Men’s Reproductive Health ......................................................................................................... 313
Chapter 54: Sexually Transmitted Infections .................................................................................................. 317
Chapter 55: Adult and Pediatric Emergency Drugs ......................................................................................... 320 [Show Less]